ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
ANGPT1 | Angiopoietin 1 | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANGPT2 | Angiopoietin 2 | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ARF6 | ADP-ribosylation factor 6 | RAS pathway related proteins
| | | | | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BRAP | BRCA1 associated protein | RAS pathway related proteins
| | | | | Expressed in all |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM3 | Calmodulin 3 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALML3 | Calmodulin-like 3 | Plasma proteins RAS pathway related proteins
| | | | | Tissue enhanced |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
CALML6 | Calmodulin-like 6 | RAS pathway related proteins
| | | | | Tissue enriched |
CDC42 | Cell division cycle 42 | Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
CHUK | Conserved helix-loop-helix ubiquitous kinase | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
CSF1R | Colony stimulating factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
EFNA1 | Ephrin-A1 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
EFNA2 | Ephrin-A2 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EFNA3 | Ephrin-A3 | Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
EFNA4 | Ephrin-A4 | Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
EFNA5 | Ephrin-A5 | Cancer-related genes Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
EGF | Epidermal growth factor | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELK1 | ELK1, member of ETS oncogene family | RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EXOC2 | Exocyst complex component 2 | RAS pathway related proteins
| | | | | Expressed in all |
FASLG | Fas ligand (TNF superfamily, member 6) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FGF10 | Fibroblast growth factor 10 | Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF13 | Fibroblast growth factor 13 | RAS pathway related proteins
| | | | | Mixed |
FGF17 | Fibroblast growth factor 17 | Cancer-related genes Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGF18 | Fibroblast growth factor 18 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF19 | Fibroblast growth factor 19 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
FGF21 | Fibroblast growth factor 21 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF3 | Fibroblast growth factor 3 | Cancer-related genes Disease related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
FGF4 | Fibroblast growth factor 4 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Not detected |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF7 | Fibroblast growth factor 7 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF9 | Fibroblast growth factor 9 | Cancer-related genes Disease related genes RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR1 | Fibroblast growth factor receptor 1 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGFR4 | Fibroblast growth factor receptor 4 | Cancer-related genes CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |